Study of EO2002 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction

Summary

This study will evaluate the safety and effectiveness of a single injection of EO2002 at one of two dose levels (150,000 or 500,000 magnetic human corneal endothelial cells \[mHCECs\]), compared with a placebo injection, in participants with corneal edema caused by corneal endothelial dysfunction.

Timeline

Start

2026-10

Primary completion

2027-08

Completion

2028-02

Drugs

Indications